1.Wolf PA，Abbott RD，Kannel WB. Atrial fibrillation as an independent risk factor for stroke：the Framingham Study［J］. Stroke，1991，22（8）：983-988.

2.Lin HJ，Wolf PA，Kelly-Hayes M，et al. Stroke severity in atrial fibrillation. The Framingham Study［J］. Stroke，1996，27（10）：1760-1764.

3.Patan è S，Marte F，Di Bella G，et al. A large left atrial thrombus mimicking an atrial tumour［J］. Int J Cardiol，2009，133（2）：e58-59.

4.Singh Y，Kharge J，Ramegowda RT，et al. Large atrial thrombus at unusual site：masquerading atrial myxoma［J］.Thromb Thrombolysis，2013，36（1）：74-76.

5.Hart RG，Pearce LA，Aguilar MI. Meta-analysis：antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation［J］. Ann Intern Med，2007，146（12）：857-867.

6.January C，Wann L，Alpert J，et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation：A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Developed in Collaboration With the Society of Thoracic Surgeons［J］. J Am Coll Cardiol，2014，64（21）：2305-2307.

7.黄从新，张澍，黄德嘉，等 .心房颤动：目前的认识和治疗建议（2018）［J］.中华心律失常杂志，2018，22（4）：279-346.

8.Kadoi Y1，Sakaguchi M，Takahashi K，et al. Acute thrombus formation in the left atrium after the termination of warfarin［J］. J Anesth，2004，18（3）：224-227.

9.Schanbacher CF，Bennett RG. Postoperative stroke after stopping warfarin for cutaneous surgery［J］.DermatolSurg，2000，26（8）：785-789.

10.Patel MR，Mahaffey KW，Garg J，et al. Rivaroxaban versus warfarinin nonvalvular atrial fibrillation［J］. N Engl J Med，2011，365（10）：883-891.

11.Granger CB，Alexander JH，McMurray JJ，et al. Apixaban versus warfarin in patients with atrial fibrillation［J］.N Engl J Med，2011，365（11）：981-992.

12.Connolly SJ，Ezekowitz MD，Yusuf S，et al. Dabigatran versus warfarin in patients with atrial fibrillation［J］. N Engl J Med，2009，361（12）：1139-1151.